Telehealth Business Plan: What to Include and What It Costs (2026)

A telehealth business plan should connect the clinical model, launch states, workforce, pharmacy approach, payment model, technology, marketing, and compliance program to specific costs. It should also separate one-time implementation expenses, recurring overhead, and variable encounter costs instead of presenting one generic startup number.

What should be included in a telehealth business plan?

A credible plan explains what the company will offer, who will provide clinical services, where patients will be located, how revenue will be collected, and which responsibilities remain with the business. The essential sections are:

1. 1Executive summary
2. 2Market and customer definition
3. 3Clinical operating model
4. 4Licensing and state expansion plan
5. 5Clinician workforce
6. 6Pharmacy and prescribing model
7. 7Revenue cycle and payments
8. 8Technology and security
9. 9Marketing and advertising
10. 10Compliance and risk management
11. 11Financial model and launch milestones

This outline works as a telehealth business plan template, but the assumptions must be customized to the service line and states in which the company intends to operate.

1. How should the executive summary describe the business?

The executive summary should state the clinical problem, target population, initial launch states, services offered, services excluded, staffing model, revenue model, and first-year capital requirement.

It should also identify whether the model includes prescriptions, laboratory testing, remote monitoring, devices, behavioral health, primary care, specialty care, or only care coordination. A direct-to-consumer cash-pay clinic has different risks and cost drivers from an employer-sponsored or payer-contracted program.

Do not assume that “telehealth” is one business model. A plan should specify whether it is:

• Direct-to-consumer
• Employer-sponsored
• Payer-contracted
• Provider-to-provider
• Cash-pay or subscription-based
• Insurance-billed
• A hybrid of these models

The summary should include break-even assumptions, but it should not present revenue or profitability as guaranteed.

2. What belongs in the market and customer section?

The market section should define the buyer and explain how payment will work, without treating demand as equivalent to reimbursement.

Potential customer groups include patients paying directly, employers, health plans, health systems, physician groups, government programs, and specialty referral partners. Each may require a different sales cycle, contracting process, credentialing approach, reporting package, and service-level commitment.

For an insurance model, document assumptions for eligibility, allowed amounts, collection rates, denials, days in accounts receivable, and credentialing delays. Medicare, Medicaid, commercial insurance, and employer contracts may apply different eligibility, coding, network, and geographic rules.

3. How do you describe the clinical operating model?

The clinical operating model should show how a person moves from intake through evaluation, escalation, follow-up, and record retention.

Include workflows for:

• Identity and patient-location verification
• Intake and clinical eligibility
• Consent and documentation
• Escalation to in-person care or emergency services
• Follow-up and continuity of care
• Medical-record ownership and retention
• Quality assurance and peer review
• Clinician supervision and delegation
• Technology failure and downtime

Patient location matters because licensing and practice requirements commonly attach to where the patient is located during care. California, for example, states that a physician treating a patient located in California through telehealth must hold a California license and follow the same standard of care and professional responsibilities that apply in person.

The platform should support privacy, security, access controls, and appropriate business-associate arrangements where applicable. HHS also emphasizes private locations and reasonable HIPAA safeguards for telehealth. Technology cannot replace a clinician’s judgment about whether remote care is appropriate.

4. What licensing costs belong in a telemedicine business plan?

A national compliance statement is not enough; the plan needs a state-by-state launch matrix. For every target state, identify the patient location, clinician license, professional entity, consent requirements, prescribing rules, supervision requirements, recordkeeping obligations, insurance, and any telehealth registration.

Budget categories may include:

• Physician and advanced-practice licenses
• State telehealth registrations
• Controlled-substance registrations, if applicable
• Professional-entity formation
• Registered-agent services
• Malpractice coverage
• Provider credentialing and payer enrollment
• State-specific legal and regulatory review

State examples show why a national estimate can mislead. In California, the Medical Board discusses telehealth consent and documentation and warns that corporate-practice concerns may arise when a management services organization advertises or arranges medical services or controls medical decisions. A founder may therefore need a physician-owned professional entity or another compliant structure, with a carefully scoped management-services agreement.

In Texas, telemedicine uses the same standard of care as comparable in-person care. Texas also has detailed delegation and prescriptive-authority requirements affecting APRNs and PAs. A model relying heavily on those clinicians should budget for compliant physician delegation, agreements, meetings, and documentation where required.

Florida provides an out-of-state telehealth registration pathway for qualifying practitioners. The pathway includes requirements such as an active, unencumbered license, a Florida registered agent, and liability coverage or financial responsibility. Eligibility depends on the profession and service, so registration should not be treated as automatic.

Pennsylvania permits licensed professionals to provide telemedicine within scope when appropriate, but the state cautions that a physical-examination requirement may still apply to a particular service. Massachusetts has a Board of Registration in Medicine policy stating that a face-to-face encounter is not universally required before telehealth delivery for physicians, while the same standard of care applies.

These are examples, not a national rule. Use qualified legal and clinical reviewers for the actual launch matrix. Founders evaluating ownership and management arrangements may also benefit from reviewing state ownership rules for medical businesses.

5. What should the clinician workforce section cover?

The workforce section should describe who provides care, when they are available, and how their work is governed.

Include the number and type of clinicians needed at each launch stage; employee-versus-contractor structure; medical director or clinical-lead responsibilities; coverage hours; response-time expectations; supervision and delegation; credentialing timelines; compensation assumptions; malpractice and tail coverage; and training.

A medical director is not a universal legal requirement. Whether the role is needed, what it may do, and how supervision operates depend on the state, profession, service line, and entity structure. The business brand or platform must not be presented as the treating clinician. Independently licensed clinicians retain responsibility for clinical decisions within their professional authority.

6. How should the pharmacy and prescribing model be planned?

The plan should make a clear choice among five operating models:

1. 1No prescribing.
2. 2Prescriptions sent to a patient’s chosen pharmacy.
3. 3A contracted mail-order or specialty pharmacy.
4. 4An owned or operated pharmacy.
5. 5A model involving compounded medication or controlled substances.

For each option, identify prescriber responsibility, pharmacy ownership and licensing, counseling, adverse-event reporting, returns and refunds, shortage contingencies, disclosures, and marketing review.

FDA states that compounded drugs are not FDA-approved for safety, effectiveness, or quality before marketing. FDA also warns telehealth companies against describing compounded drugs as FDA-approved, generic versions of approved products, equivalent to approved products, or supported by claims that are not properly substantiated.

Controlled substances require separate analysis. DEA and HHS extended specified telemedicine flexibilities through December 31, 2026, including certain remote Schedule II–V prescribing pathways, subject to applicable federal and state requirements. The plan should identify whether DEA registration, electronic prescribing of controlled substances, state registration, an in-person evaluation, or other conditions apply.

The business should verify pharmacy licensing and the responsibilities of each pharmacy relationship rather than treating a platform’s network description as a substitute for due diligence.

7. What costs belong in revenue cycle and payments?

The financial section should model how money moves from a patient, employer, or payer into the business and how refunds, denials, and chargebacks affect cash flow.

Budget for cash-pay pricing, subscriptions, insurance eligibility, claims submission, coding and documentation, clearinghouse fees, denial management, refunds, chargebacks, no-shows, cancellations, financial assistance, credentialing, contracting, and fraud, waste, and abuse controls.

Recurring plans also need clear terms and cancellation workflows. The Restore Online Shoppers’ Confidence Act requires online sellers of recurring plans to clearly disclose material terms before collecting billing information, obtain express informed consent before charging, and provide a simple way to stop recurring charges. The FTC’s 2024 amendments to its Negative Option Rule are not in force: the Eighth Circuit vacated them on July 8, 2025, and the FTC’s March 11, 2026 advance notice of proposed rulemaking is only a proposal.

For Medicare, CMS’s CY 2026 Physician Fee Schedule materials changed telehealth-list and payment-related policies. CMS also stated that, beginning January 31, 2026, Medicare beneficiaries generally must be in a medical facility and rural area for non-behavioral-health telehealth, subject to applicable exceptions and later policy changes. Verify the service date, benefit category, and current CMS instructions before modeling Medicare revenue.

8. What technology should a telehealth startup budget for?

Technology costs should reflect the entire operating workflow, not just video visits.

Plan for video and audio, scheduling, intake, an EHR, e-prescribing, EPCS where applicable, identity and location verification, messaging, payment processing, claims and eligibility integrations, remote monitoring, analytics, customer support, downtime recovery, cybersecurity testing, and incident response.

A white-label platform can coordinate several infrastructure relationships, but it does not automatically transfer clinical, legal, pharmacy, privacy, or billing obligations. MDLaunchr is the brand behind WhiteLabelClinic.com, a platform designed to help qualified businesses evaluate and coordinate technology, operational, compliance, clinical-network, and fulfillment relationships involved in launching telehealth services.

Founders comparing branded and private-label models can use private-label versus white-label telehealth differences to clarify ownership, customization, data control, and operational responsibility. The right questions for any platform include: Who owns patient data? Who contracts with clinicians? Who handles support? What happens when a patient is in an unapproved state? What happens when video fails or in-person care is needed?

9. How much does it cost to start a telehealth company?

There is no reliable universal national startup price. Official sources generally describe requirements and payment rules rather than a standard telehealth startup cost. Build a company-specific budget using these categories:

Keep clinician compensation, platform fees, marketing, and pharmacy costs on separate lines. Combining them into one operating-expense figure makes break-even analysis difficult to audit.

Model at least three scenarios:

• Cash pay: completed visits, subscription retention, acquisition cost, refunds, and support labor.
• Insurance: allowed amount, collection rate, denial rate, accounts-receivable days, and credentialing delay.
• Employer or payer contract: implementation fee, per-member-per-month revenue, utilization, reporting, and service-level costs.

To review infrastructure options and current commercial information, see WhiteLabelClinic.com pricing. Pricing information should be evaluated alongside the responsibilities and third-party costs that remain outside a platform arrangement.

What is the best order for building the plan?

Use this sequence before committing to a launch date:

1. 1Define the service, customer, payment model, and excluded services.
2. 2Choose initial states and build the patient-location licensing matrix.
3. 3Confirm the clinical workforce, supervision, and escalation model.
4. 4Decide whether prescriptions, laboratories, devices, or controlled substances are included.
5. 5Map technology, pharmacy, payment, and recordkeeping relationships.
6. 6Obtain legal, clinical, privacy, and advertising review.
7. 7Separate launch, recurring, and per-encounter costs.
8. 8Stress-test cash pay, insurance, and employer-contract scenarios.
9. 9Set launch gates for licenses, clinician coverage, testing, policies, and support.
10. 10Revisit assumptions before expanding into another state or service line.

Telehealth business plan checklist

Before treating the plan as launch-ready, confirm that it answers:

• Which entity owns the business brand and which entity provides medical care?
• Where may each clinician practice, and where may each patient be located?
• What services are included and excluded?
• Who makes clinical decisions?
• What happens when remote care is not appropriate?
• Are consent, records, privacy, and security workflows documented?
• Are pharmacy partners independently evaluated?
• Are compounded-drug and medication claims reviewed?
• Are controlled-substance rules analyzed separately?
• Are payer assumptions supported by current CMS or contract requirements?
• Are subscription terms and cancellation processes clear?
• Are marketing claims substantiated and reviewed?
• Are launch and recurring costs separated by category?

MDLaunchr and WhiteLabelClinic.com can support a compliance-first infrastructure evaluation, but they do not replace qualified legal counsel, licensed clinicians, regulators, pharmacies, payers, or other required relationships. Explore pricing and platform scope.